LoginSignup
Stratec logo

Stratec

Stock
Stock
ISIN: DE000STRA555
Ticker: SBS
DE000STRA555
SBS

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Stratec has so far distributed $0.684 in 2026. The next dividend will be paid on 26.06.2027

$0.823

CHART BY

Frequently asked questions

The market capitalization of Stratec is $347.47M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Stratec's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0378. EPS indicates the company's profitability on a per-share basis.
Currently, 7 analysts cover Stratec's stock, with a consensus target price of $31.57. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Stratec reported a revenue of $284.46M.
Stratec's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $36.07M. EBITDA measures the company's overall financial performance.
Stratec employs approximately 1,403 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Stratec is 7.58M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$347.47M
EPS (TTM) 
-$0.0378
Free Float 
7.58M
Revenue (TTM) 
$284.46M
EBITDA (TTM) 
$36.07M

Pricing

1D span
$27.84$28.87
52W span
$18.90$38.58

Analyst Ratings

The price target is $31.57 and the stock is covered by 7 analysts.

Buy

5

Hold

2

Sell

0

Information

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1,403
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE000STRA555
Primary Ticker
SBS

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin